Scottish Medicines Consortium enables access to treatment for rare inherited bone disorder in children
February 18, 2020Manufacturing and Production Crysvita, Kyowa Kirin, SMC, Scottish Medicine Consortium, nhs scotland
The Scottish Medicines Consortium (SMC) has enabled access to Kyowa Kirin’s Crysvita (burosumab) for the NHS in Scotland to treat …
Novartis’ Beovu approved in Europe after outclassing Eylea in wet age-related macular degeneration
February 18, 2020Manufacturing and Production, Sales and Marketing Beovu, Eylea, Novartis, Regeneron, macular degeneration, pharma
The European Commission (EC) has chosen to approve Novartis’ Beovu (brolucizumab) injection, it has emerged, as a treatment for wet …
NICE gives initial ‘no’ to NHS England for kidney cancer drug
February 18, 2020Manufacturing and Production NHS England, NICE, clinical trials, inlyta, keytruda
The National Institute for Health and Care Excellence (NICE) has not recommended Keytruda (pembrolizumab) and Inlyta (axitinib) for the treatment …
Rapid testing to help combat worst UK outbreak of HIV in 30 years
February 18, 2020Manufacturing and Production AIDS, HIV, HIV England, HIV Scotland, HIV epidemic, HIV/AIDS
New HIV tests that provide results in minutes are being used in Glasgow to fight a recent outbreak of HIV. …
Patient Experience: Living with multiple rare diseases
February 17, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, patient experience, pharma, rare disease
Carole Scrafton discusses her experience living with Ehlers-Danlos syndrome alongside other rare conditions that have manifested throughout her life, and …
Lawsuit against FDA claims Bernie Sanders played role in approval of rival drug
February 17, 2020Research and Development, Sales and Marketing Bernie, Bernie Sanders, Catalyst Pharmaceuticals, FDA, TRUMP FDA, US FDA
Catalyst Pharmaceutical is attempting to show in court that pressure from US Senator Bernie Sanders led to the approval of …
Eisai releases new Phase 2 data for levatinib+everolimus combo in advanced kidney cancer
February 17, 2020Research and Development, Sales and Marketing Cancer, Eisai, Kidney cancer, Lenvima, pharma, renal cell carcinoma
New Phase 2 data has been revealed for Eisai’s Lenvima (levatinib), delivered alongside Novartis’ everolimus, for the treatment of unresectable …
Strong Phase 3 data for Takeda’s subcutaneous Entyvio in moderate to severe Crohn’s disease
February 17, 2020Research and Development, Sales and Marketing Crohn’s disease, Entyvio, Takeda, crohn's disease, pharma
Takeda has shared positive new Phase 3 data on a subcutaneous formulation of its gut-selective biologic Entyvio (vedolizumab) as a …
Experts call on NICE to recommended a ban on OTC codeine sales
February 17, 2020Research and Development, Sales and Marketing Codein, NICE, opioid crisis, opioids, prescription drugs
Experts have called for a ban on the sale of over the counter codeine as NICE is set to publish …
India considering export restrictions on antibiotics due to coronavirus
February 17, 2020Sales and Marketing Chinese Coronavirus, Indian Pharma, Wuhan, china coronavirus, coronavirus, drugs
The Indian government is considering an export ban on antibiotics, vitamins and hormones due to the lockdown of Hubei province, …
Top Ten most popular articles on Pharmafile.com this week
February 14, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, Chinese Coronavirus, Wuhan, Wuhan Coronavirus, china coronavirus, coronavirus
The coronavirus continues to dominate the news, with the disease finally getting treated. In America, a patient has been successfully …
Mumps cases in England rocket four-fold to highest point in a decade
February 14, 2020Medical Communications, Research and Development MMR vaccine, Vaccine, anti-vaccine, pharma
The incidence of mumps in the England has reached its highest level in 10 years, prompting warnings from health officials …
Global drug market’s production line threatened by coronavirus
February 14, 2020Medical Communications Chinese Coronavirus, Drug markets, Wuhan Coronavirus, china epidemic, coronavirus, drugs, epidemic, pharma
The global drug market is facing issues over production due to the coronavirus ravaging the supply line from China. In …
Eisai withdraws weight loss drug Belviq after FDA highlights cancer risk
February 14, 2020Medical Communications, Research and Development, Sales and Marketing Belviq, Eisai, FDA, pharma
The FDA has requested that Eisai withdraw its weight loss drug Belviq (lorcaserin) and Belviq XR from the US market …
Insulin pumps tied to over 2,000 injuries recalled
February 14, 2020Medical Communications Type 1 diabetes, diabetes, insulin, type 1, type 2, type 2 diabetes
Over 300,000 insulin pumps have been recalled by Medtronic after injuries and one death were reported due to devices malfunctioning. …
Sanofi axes four major players from its executive committee
February 13, 2020Manufacturing and Production, Medical Communications Sanofi, appointments, pharma
Sanofi has announced it will cull its executive committee under plans orchestrated by new Chief Executive Officer Paul Hudson, who …
Lilly and Incyte’s atopic dermatitis drug shows promise at Phase 3
February 13, 2020Sales and Marketing Eli Lilly, Incyte, baricitinib, pharma
Eli Lilly and Incyte have pulled back the curtain on Phase 3 data on their oral selective JAK inhibitor baricitinib …
Forecasts show branded generics will double in revenue with Asia driving growth
February 13, 2020Business Services branded drugs, drug patents, patents
Branded generic drugs are expected to grow in global sales by 8% by 2029, but Europe and America will not …
Highest fatalities from coronavirus recorded in a single day due to new classifications
February 13, 2020Business Services China, UK Coronavirus, Wuhan, Wuhan Coronavirus, coronavirus
The coronavirus outbreak reached its deadliest day since it began in December. Roughly 242 deaths have been reported in Hubei …
NICE does not recommend cancer drug combination to the NHS
February 13, 2020Business Services Cancer, Kidney cancer, NHS, NICE, keytruda, kidney disease
NICE has published draft guidance that does not recommend a new drug combination to combat untreated advanced renal cell carcinoma …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
